Follow the Veradermics, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). The latest transaction was reported on 19 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Averill Master Fund, Ltd.. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Veradermics, Inc. is a company listed on the XNAS market. It specializes in developing innovative solutions for the dermatology sector.